To read this content please select one of the options below:

Kwoka’s Mergers, Merger Control, and Remedies: Rejoinder to Kwoka

Healthcare Antitrust, Settlements, and the Federal Trade Commission

ISBN: 978-1-78756-600-2, eISBN: 978-1-78756-599-9

Publication date: 29 August 2018

Abstract

John Kwoka’s Mergers, Merger Control, and Remedies is a meta-analysis of “retrospective” academic studies of consummated mergers and other horizontal arrangements. Based on this meta-analysis, Kwoka strongly criticizes federal enforcement policies, claiming that the agencies permit far too many anticompetitive mergers to go unchallenged, and are far too willing to accept remedies that fail to prevent a significant loss of competition. Kwoka claims further that this excessive leniency is the culmination of a trend reflecting deliberate policy choices made over the last several decades.

In a forthcoming critique, Vita and Osinski challenge Kwoka’s analysis and his conclusions, identifying serious flaws in the size, construction, and composition of his sample, and in the statistical analysis of the data drawn from that sample. In a published response to Vita and Osinski, Professor Kwoka offers a number of objections and counter-arguments. In this rejoinder, I respond to Professor Kwoka.

Keywords

Acknowledgements

Acknowledgments

I thank James Frost, Ginger Jin, Dan Hosken, Alison Oldale, Dave Osinski, Dave Schmidt, Lou Silvia, and Chris Taylor for helpful comments. Remaining errors are mine.

Citation

Vita, M. (2018), "Kwoka’s Mergers, Merger Control, and Remedies: Rejoinder to Kwoka ", Healthcare Antitrust, Settlements, and the Federal Trade Commission (Research in Law and Economics, Vol. 28), Emerald Publishing Limited, Leeds, pp. 433-444. https://doi.org/10.1108/S0193-589520180000028010

Publisher

:

Emerald Publishing Limited

Copyright © 2018 Emerald Publishing Limited